Aptadir Therapeutics
Reprogramming DNA methylation by RNA therapeutics to cure intractable conditions
We discovered a new class of specialized RNAs interacting with the mammalian DNMT1 – DNMT1-interacting RNAs (DiRs). DiRs prevent DNA methylation and gene silencing in a locus-specific manner, by binding and inhibiting DNMT1 are able to reactivate suppressed genes
- Totale raccolto
- 1,4 Mln €
- Round
- 1
- Ultimo round
- Pre-Seed
Team
Nessun founder mappato su questa scheda. Aggiungili
Round di finanziamento
1 round · 1.433.000 € raccolti.
| Data | Round | Importo | Fonte |
|---|---|---|---|
| 29 set 2024 | Pre-Seed | 1.433.000 € | annuncio |